MicroRNAs contribute to cancer development by acting as oncogenes or tumor suppressor genes. However, only a few microRNA target genes were determined. We identified a nearly perfect complementarity between miR-206 and the 3-untranslated regions of both mouse and human notch3. Expression of miR-206 decreased the luciferase activity dose-dependently when cotransfected with the mouse or human notch3 3-untranslated region-luciferase reporter containing the miR-206 target site in HeLa cells. This suppression was relieved by deletion and mutation of the miR-206-binding site and was partially recovered by expression of notch3 or by a specific inhibitor of miR-206. Interestingly, overexpression of miR-206 decreased the levels of both Notch3 protein and mRNA. Expression of miR-206 markedly induced apoptotic cell death and blocked the anti-apoptotic activity of Notch3. In addition, ectopic expression of miR-206 inhibited HeLa cell migration and focus formation. Therefore, we identified miR-206 as a pro-apoptotic activator of cell death, which was associated with its inhibition of notch3 signaling and tumor formation. The inhibition of cancer cell migration and focus formation by miR-206 strongly suggests that miR-206 may function as a novel tumor suppressor.
MicroRNAs (miRNAs)2 regulate gene expression by binding to the 3Ј-untranslated regions (3Ј-UTRs) of specific mRNAs (1) and play important roles in development, proliferation, and differentiation (2-4). Recent studies revealed the involvement of miRNAs in apoptosis signaling (5). For instance, miR-15 and miR-16 have been shown to induce apoptosis by targeting Bcl-2 (6). miR-34a can be regulated by p53, which promotes apoptosis (7,8). Despite the growing evidence for their importance in carcinogenesis (9), limited information is available about their function in human cancers. The future challenges are to identify the biological targets of miRNAs and the signaling pathways they regulate during oncogenesis.Early studies identified miR-206 as a skeletal musclespecific miRNA involved in muscle development (10 -12). Recent studies showed that miR-206 targets the estrogen receptor (13) and is down-regulated in estrogen receptorpositive breast cancer (14). It is thus postulated that miR-206 may be associated with breast cancer metastasis (15). In addition to its high expression in muscle, miR-206 was also reported to be expressed in brain associated with schizophrenia (16) and in brown adipocytes (17). The level of miR-206 is increased in bone marrow-derived DC19ϩ WM cells associated with Waldenström macroglobulinemia (18). Despite a broader tissue-specific expression than originally anticipated, the physiological function of miR-206 in cancer progression remains largely unknown.In this study, we report several novel findings. We identify notch3 (Notch homolog 3) as a novel miR-206 target. We reveal miR-206 as a potent apoptotic cell death inducer via cross-talk with notch3. We further show that miR-206 inhibits tumor cell migration and focus formation. Our study suggests mi...